Iranian Journal of Medical Sciences

Document Type : Original Article(s)

Authors

1 Department of Pediatric Cardiology, Rajaiee Heart Center, Tehran, Iran

2 Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

3 Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

10.30476/ijms.2021.88464.1919

Abstract

Background: There is no compelling evidence to prove an association between serum free L-carnitine levels and changes in left ventricular (LV) geometry. The present study aimed to evaluate a possible association between these parameters.
Methods: In a cross-sectional study, 504 outpatients were randomly selected among those registered at Sanandaj Pediatric Heart Clinic (Sanandaj, Iran) during 2014-2020. The patients aged one to 25 years and were presented with cardiac complaints. The serum L-carnitine levels of all patients were evaluated and associated with changes in LV geometry measured by echocardiography. The association was assessed using the Chi squared test, Fisher’s exact test, and one-way ANOVA with post hoc Tukey test. Data were analyzed using SPSS software (version 22.0). P≤0.05 was considered statistically significant.
Results: The mean serum L-carnitine levels in the normal, low, and high serum groups were 52.69, 14.16, and 178.67 nmol/dL, respectively. There was a significant statistical association between abnormal serum levels of free L-carnitine and changes in LV geometry (P<0.001).
Conclusion: Our findings are indicative of an association between abnormal serum L-carnitine levels and changes in LV geometry in pediatric and adolescent patients.

Keywords

  1. Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger. Eur Heart J Cardiovasc Imaging. 2015;16:577-605. doi: 10.1093/ehjci/jev076. PubMed PMID: 25995329.
  2. Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G, Romano C, et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol. 2006;17:218-26. doi: 10.1681/ASN.2005030276. PubMed PMID: 16280471.
  3. Nishimura M, Tokoro T, Takatani T, Sato N, Nishida M, Hashimoto T, et al. Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine. Springerplus. 2015;4:353. doi: 10.1186/s40064-015-1119-z. PubMed PMID: 26191480; PubMed Central PMCID: PMCPMC4503700.
  4. Richey PA, Disessa TG, Somes GW, Alpert BS, Jones DP. Left ventricular geometry in children and adolescents with primary hypertension. Am J Hypertens. 2010;23:24-9. doi: 10.1038/ajh.2009.164. PubMed PMID: 19851297; PubMed Central PMCID: PMCPMC2795788.
  5. Woroniecki RP, Kahnauth A, Panesar LE, Supe-Markovina K. Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review. Front Pediatr. 2017;5:101. doi: 10.3389/fped.2017.00101. PubMed PMID: 28553631; PubMed Central PMCID: PMCPMC5425592.
  6. Mottonen MJ, Ukkola O, Lumme J, Kesaniemi YA, Huikuri HV, Perkiomaki JS. Cardiac Remodeling from Middle Age to Senescence. Front Physiol. 2017;8:341. doi: 10.3389/fphys.2017.00341. PubMed PMID: 28603501; PubMed Central PMCID: PMCPMC5445175.
  7. Li T, Li G, Guo X, Li Z, Sun Y. Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: a rural cohort population study. BMC Cardiovasc Disord. 2021;21:238. doi: 10.1186/s12872-021-02055-w. PubMed PMID: 33980151; PubMed Central PMCID: PMCPMC8114526.
  8. Castello Brescane R. The prognostic significance of left ventricular geometry: fantasy or reality? Rev Esp Cardiol. 2009;62:235-8. doi: 10.1016/s1885-5857(09)71550-6. PubMed PMID: 19268065.
  9. Lavie CJ, Milani RV, Shah SB, Gilliland YE, Bernal JA, Dinshaw H, et al. Impact of left ventricular geometry on prognosis-a review of ochsner studies. Ochsner J. 2008;8:11-7. PubMed PMID: 21603551; PubMed Central PMCID: PMCPMC3096422.
  10. Oktay AA, Lavie CJ, Milani RV, Ventura HO, Gilliland YE, Shah S, et al. Current Perspectives on Left Ventricular Geometry in Systemic Hypertension. Prog Cardiovasc Dis. 2016;59:235-46. doi: 10.1016/j.pcad.2016.09.001. PubMed PMID: 27614172.
  11. Masai K, Mano T, Goda A, Sugahara M, Daimon A, Asakura M, et al. Correlates and Prognostic Values of Appearance of L Wave in Heart Failure Patients With Preserved vs. Reduced Ejection Fraction. Circ J. 2018;82:2311-6. doi: 10.1253/circj.CJ-18-0417. PubMed PMID: 30022769.
  12. Cuspidi C, Sala C, Tadic M, Gherbesi E, Facchetti R, Grassi G, et al. High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis. J Hypertens. 2019;37:1312-9. doi: 10.1097/HJH.0000000000002063. PubMed PMID: 30829730.
  13. Zile MR, Gaasch WH, Patel K, Aban IB, Ahmed A. Adverse left ventricular remodeling in community-dwelling older adults predicts incident heart failure and mortality. JACC Heart Fail. 2014;2:512-22. doi: 10.1016/j.jchf.2014.03.016. PubMed PMID: 25194295.
  14. Kaneko M, Fukasawa H, Ishibuchi K, Niwa H, Yasuda H, Furuya R. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient. Intern Med. 2018;57:3593-6. doi: 10.2169/internalmedicine.1055-18. PubMed PMID: 30146554; PubMed Central PMCID: PMCPMC635540
  15. Mahapatra S, Ananth A, Baugh N, Damian M, Enns GM. Triheptanoin: A Rescue Therapy for Cardiogenic Shock in Carnitine-acylcarnitine Translocase Deficiency. JIMD Rep. 2018;39:19-23. doi: 10.1007/8904_2017_36. PubMed PMID: 28689308; PubMed Central PMCID: PMCPMC5953892.
  16. Tousson E, Hafez E, Zaki S, Gad A. The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin. Environ Sci Pollut Res Int. 2016;23:20600-8. doi: 10.1007/s11356-016-7220-1. PubMed PMID: 27464663.
  17. Deswal S, Bijarnia-Mahay S, Manocha V, Hara K, Shigematsu Y, Saxena R, et al. Primary Carnitine Deficiency - A Rare Treatable Cause of Cardiomyopathy and Massive Hepatomegaly. Indian J Pediatr. 2017;84:83-5. doi: 10.1007/s12098-016-2227-7. PubMed PMID: 27581592.
  18. Fotino AD, Sherma A. Patient with Eating Disorder, Carnitine Deficiency and Dilated Cardiomyopathy. J La State Med Soc. 2015;167:162-4. PubMed PMID: 27159507.
  19. Wang Y, Xu Y, Zou R, Wu L, Liu P, Yang H, et al. Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children. Paediatr Drugs. 2018;20:285-90. doi: 10.1007/s40272-018-0284-2. PubMed PMID: 29468383; PubMed Central PMCID: PMCPMC5954011.
  20. Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H. Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2017;2017:6274854. doi: 10.1155/2017/6274854. PubMed PMID: 28497060; PubMed Central PMCID: PMCPMC5406747.
  21. Yoshihisa A, Watanabe S, Yokokawa T, Misaka T, Sato T, Suzuki S, et al. Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction. ESC Heart Fail. 2017;4:360-4. doi: 10.1002/ehf2.12176. PubMed PMID: 28772033; PubMed Central PMCID: PMCPMC5542723.
  22. Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY. l-Carnitine and heart disease. Life Sci. 2018;194:88-97. doi: 10.1016/j.lfs.2017.12.015. PubMed PMID: 29241711.
  23. Lahrouchi N, Lodder EM, Mansouri M, Tadros R, Zniber L, Adadi N, et al. Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death. Eur J Hum Genet. 2017;25:783-7. doi: 10.1038/ejhg.2017.22. PubMed PMID: 28295041; PubMed Central PMCID: PMCPMC5477358.
  24. Seth P, Wu X, Huang W, Leibach FH, Ganapathy V. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J Biol Chem. 1999;274:33388-92. doi: 10.1074/jbc.274.47.33388. PubMed PMID: 10559218.
  25. Iwamoto J, Honda A, Miyamoto Y, Miyazaki T, Murakami M, Saito Y, et al. Serum carnitine as an independent biomarker of malnutrition in patients with impaired oral intake. J Clin Biochem Nutr. 2014;55:221-7. doi: 10.3164/jcbn.14-77. PubMed PMID: 25411530; PubMed Central PMCID: PMCPMC4227833.
  26. Ringseis R, Keller J, Eder K. Basic mechanisms of the regulation of L-carnitine status in monogastrics and efficacy of L-carnitine as a feed additive in pigs and poultry. J Anim Physiol Anim Nutr (Berl). 2018;102:1686-719. doi: 10.1111/jpn.12959. PubMed PMID: 29992642.
  27. van Vlies N, Ferdinandusse S, Turkenburg M, Wanders RJ, Vaz FM. PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim Biophys Acta. 2007;1767:1134-42. doi: 10.1016/j.bbabio.2007.07.001. PubMed PMID: 17692817.
  28. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J. 2002;361:417-29. doi: 10.1042/0264-6021:3610417. PubMed PMID: 11802770; PubMed Central PMCID: PMCPMC1222323.
  29. Frigeni M, Balakrishnan B, Yin X, Calderon FRO, Mao R, Pasquali M, et al. Functional and molecular studies in primary carnitine deficiency. Hum Mutat. 2017;38:1684-99. doi: 10.1002/humu.23315. PubMed PMID: 28841266; PubMed Central PMCID: PMCPMC5665702.
  30. Fu L, Huang M, Chen S. Primary carnitine deficiency and cardiomyopathy. Korean Circ J. 2013;43:785-92. doi: 10.4070/kcj.2013.43.12.785. PubMed PMID: 24385988; PubMed Central PMCID: PMCPMC3875693.
  31. Knottnerus SJG, Bleeker JC, Wust RCI, Ferdinandusse S, L IJ, Wijburg FA, et al. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle. Rev Endocr Metab Disord. 2018;19:93-106. doi: 10.1007/s11154-018-9448-1. PubMed PMID: 29926323; PubMed Central PMCID: PMCPMC6208583.
  32. El Mously S, Abdel Ghaffar H, Magdy R, Hamza S, Mansour M. Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens. Egypt J Neurol Psychiatr Neurosurg. 2018;54:37. doi: 10.1186/s41983-018-0033-z. PubMed PMID: 30546248; PubMed Central PMCID: PMCPMC6267633.
  33. Lambert ME, Shipley K, Holbrook I, Faragher EB, Irving MH. Serum carnitine levels in normal individuals. JPEN J Parenter Enteral Nutr. 1988;12:143-6. doi: 10.1177/0148607188012002143. PubMed PMID: 3361681.
  34. Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G, et al. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Heart J Cardiovasc Imaging. 2014;15:680-90. doi: 10.1093/ehjci/jet284. PubMed PMID: 24451180; PubMed Central PMCID: PMCPMC4402333.
  35. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, et al. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2006;19:1413-30. doi: 10.1016/j.echo.2006.09.001. PubMed PMID: 17138024.
  36. Reddy V, Bhandari S, Seymour AM. Myocardial function, energy provision, and carnitine deficiency in experimental uremia. J Am Soc Nephrol. 2007;18:84-92. doi: 10.1681/ASN.2005080876. PubMed PMID: 17182887.
  37. Ueland T, Svardal A, Oie E, Askevold ET, Nymoen SH, Bjorndal B, et al. Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis. Int J Cardiol. 2013;167:1892-9. doi: 10.1016/j.ijcard.2012.04.150. PubMed PMID: 22622056.
  38. Longo N. Primary Carnitine Deficiency and Newborn Screening for Disorders of the Carnitine Cycle. Ann Nutr Metab. 2016;68:5-9. doi: 10.1159/000448321. PubMed PMID: 27931018.
  39. Stanley CA, Sunaryo F, Hale DE, Bonnefont JP, Demaugre F, Saudubray JM. Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency. J Inherit Metab Dis. 1992;15:785-9. doi: 10.1007/BF01800021. PubMed PMID: 1434517.
  40. Almannai M, Alfadhel M, El-Hattab AW. Carnitine Inborn Errors of Metabolism. Molecules. 2019;24. doi: 10.3390/molecules24183251. PubMed PMID: 31500110; PubMed Central PMCID: PMCPMC6766900.
  41. Kahonen MT, Ylikahri RH. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations. Atherosclerosis. 1979;32:47-56. doi: 10.1016/0021-9150(79)90146-1. PubMed PMID: 465113.
  42. Lee WS, Kim J. Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions. PPAR Res. 2015;2015:271983. doi: 10.1155/2015/271983. PubMed PMID: 26587015; PubMed Central PMCID: PMCPMC4637490.